National Healthcare Properties, Inc. Q3 FY2026 earnings call

• Strategic Transformation: NHP is completing the exit of its OMF segment by selling or placing under agreement 126 properties for approximately $1.1 billion in gross proceeds. This positions NHP as one of only two public pure-play senior housing operating REITs.
• Occupancy & Pricing Strategy: Short-term concessions used to boost occupancy are now rolling off. The strategy succeeded, raising same-store occupancy to 86.7%. Management notes increased pricing elasticity at higher occupancy levels, with new leases executing at 2027 rates that include escalators.
• Operational Efficiency: Same-store REVPOR grew 4% year-over-year to $6,454. Margin expansion is driven by operating leverage where occupancy increases do not require proportional staffing hikes.
• Acquisition Pipeline: NHP has an active pipeline of ~$388 million across 1,385 units (primarily assisted living/memory care). These assets generally have higher occupancy than the current same-store portfolio. Acquisitions are focused on 'A-class' operators in secondary markets, particularly the Midwest.
• Balance Sheet Strengthening: Proceeds from OMF sales and credit facility recasting ($1.2B total commitments) are being used to retire secured debt and preferred equity. Net debt/EBITDA was slightly over 6x but is expected to drop significantly below 5x to align with investment-grade peers.
• Operator Partnerships: Four existing partners (Senior Lifestyle, Discovery, AgeWell, Priority Life Care) manage 60 communities. A fifth partner, Sincerely Senior Living, is expected via near-term acquisition. Long-term goal is >10 operators to scale best practices.

The company is transitioning to a pure-play senior housing operating REIT. The SHOP segment drove all growth, with same-store cash NOI increasing 13.6% year-over-year (15.1% excluding one-time insurance recovery) and same-store cash NOI margin expanding 150 basis points to 24.3%. Same-store average occupancy reached 86.7%, up 220 basis points year-over-year. The Outpatient Medical Facilities (OMF) segment is being exited; its remaining same-store portfolio showed flattish year-over-year NOI growth due to prior-year revenue catch-ups, though it saw a 3.4% sequential increase from Q2.

• Full-Year 2026 SHOP Cash NOI Growth: Increased to 16.5% - 18.5% (previously lower).
• Full-Year 2026 Acquisitions: $425 million - $645 million (low end includes YTD closings; high end includes Q4 pending deals).
• Full-Year 2026 Dispositions: Approximately $1.1 billion (includes all OMF exits except four closing in early 2027, plus two non-core SHOP assets).
• G&A and Equity Compensation: Guidance remains unchanged from the previous quarter.
• OMF Same-Store NOI: Discontinued guidance; expects Q4 same-store NOI to be consistent with Q3 totals before further dispositions.
• FFO per Share: No guidance provided for 2026; management plans to issue inaugural FFO per share guidance with Q4 2026 results in early 2027 once balance sheet stabilization is complete.

• Execution Risk on Dispositions: Closing the remaining OMF transactions depends on customary conditions and loan assumptions, though management sees no major hurdles.
• Earnings Volatility: Timing-related volatility may persist during the OMF exit and balance sheet transformation phase.
• Market Competition: While levered buyers have stepped back, competition remains from local owner-operators and developers.
• Asset Quality Variance: Some legacy assets ('watch list') continue to struggle with occupancy or rates, requiring active management or potential divestiture if they fail to improve.
• Regulatory/Compliance: Standard operational risks inherent to healthcare real estate, including regulatory changes affecting payer mixes.

Q: With concessions burning off, how will RevPAR growth mix shift into 2027? / A: Management expects RevPAR strength to remain intact or improve. New residents are already paying 2027 rates with escalators, and higher-occupancy communities are realizing pricing power. While seasonality typically weighs on Q4, management is optimistic about top-line continuity into next year as occupancy gains stabilize.

Q: What is the long-term leverage target after deleveraging from OMF sales? / A: Management aims for a net debt/EBITDA ratio definitively below five times, consistent with investment-grade peers. They expect leverage to decrease further over time as internal growth generates cash flow and equity funding becomes more viable, prioritizing a stabilized, investment-grade-aligned capital structure.

Q: How does the quality and yield profile of the acquisition pipeline compare to the same-store portfolio? / A: The pipeline assets generally have higher occupancy (high 80s vs. mid 80s) and higher initial RevPAR ($150-$200/month above same-store). Year-one yields sit around 7.5% with ~130 bps of expansion by year three. Management focuses on assets needing minor CapEx (common area/unit refresh) rather than those requiring fundamental repairs, targeting strong operator partnerships for efficiency gains.

Q: Is the concession strategy a permanent tool or a one-time event? / A: It was largely a one-time event to jumpstart occupancy in specific low-performing assets. Concessions are now kept in the 'toolbox' for case-by-case use in monitored 'focus communities,' but broad-based packages are no longer being deployed. The focus has shifted to driving rate and margin at properties surpassing 85% occupancy.

Q: Why did you sell certain SHOP assets despite having them in your portfolio? / A: Divestitures were strategic prunes. One California asset was sold due to inefficiency of isolated ownership and attractive land value for a buyer willing to invest CapEx. Another was sold because management lacked optimism in its ability to reach target occupancy levels. The firm continues to evaluate assets, preferring to own only those where they can drive institutional-level operational improvements.